title: Beyond The Needle: Biotech's Delivery Challenge.
abstract: Finding new ways to administer biologics could lead to higher patient acceptance and lower costs, and prove crucial as biotech companies release products aimed at more prevalent diseases. Here's a look at the emerging world of noninjectable biologics.
authors: Linda Hull
authors: LH
authors: Felcone